
Bestselling author Colleen Hoover is sharing a health update with her many readers and fans.
The "It Ends with Us" author revealed she was diagnosed with cancer and underwent treatment in an Instagram story photo post Monday, writing, "Second to last day of radiation! I wish I could blame my hair and facial expressions on @texas.oncology but they've been great. Hope you never need them, but highly recommend them."
In an earlier Facebook post on Friday, Hoover wrote that she had received test results back from a geneticist that explained her cancer did not stem from "family genes" and was not tied to HPV or hormonal factors.
More people are living 5 years after cancer diagnosis, new data shows
She added that she was "happy and grateful to be alive."
Hoover has not revealed the type of cancer with which she was diagnosed.
The author was noticeably absent from the October 2025 premiere for the movie "Regretting You," which was adapted from her 2019 book of the same name.
"I'm super bummed, but am having an unavoidable surgery and can't travel for a while," Hoover wrote in an Instagram post at the time.
Hoover's latest book, "Woman Down," is out Jan. 13.
LATEST POSTS
- 1
Pick Your #1 game to observe - 2
Careful Nurturing: Techniques for Bringing up Tough Children - 3
Drones, physics and rats: Studies show how the people of Rapa Nui made and moved the giant statues – and what caused the island’s deforestation - 4
Must-See Attractions in France - 5
Instructions to Investigate Different Open Record Extra Offers Actually
Dominating the Art of Composing: Creator Bits of knowledge
The 10 Most Famous Works of art Ever
The Best Web-based Courses for Expertise Improvement
Getting through a Lifelong Change: Individual Examples of overcoming adversity
Explosions heard across Tehran after IDF announces wave of strikes on regime terror targets
Zendaya serves bridal-coded fashion with old, new and borrowed gowns for ‘The Drama’ press tour
Blue Origin’s New Glenn rocket landed its booster on a barge at sea – an achievement that will broaden the commercial spaceflight market
Moderna to complete US mRNA manufacturing network with $140 million investment
Journeys That could only be described as epic: Delightful Voyage Lines All over the Planet













